Key statistics
On Friday, Biohaven Ltd (BHVN:NYQ) closed at 13.93, 1.35% above its 52-week low of 13.75, set on Jul 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.62 |
---|---|
High | 14.77 |
Low | 13.81 |
Bid | 13.98 |
Offer | 14.30 |
Previous close | 15.03 |
Average volume | 1.75m |
---|---|
Shares outstanding | 102.11m |
Free float | 85.42m |
P/E (TTM) | -- |
Market cap | 1.42bn USD |
EPS (TTM) | -9.36 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
- Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor
- Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)
- Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors
- FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia
- Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments
- Biohaven Announces Investment up to $600 Million by Oberland Capital
More ▼